Nuveen’s Structure Therapeutics GPCR Stock Holding History

Nuveen’s Portfolio GPCR Stock Details GPCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$25.2K	Buy	+770	New	+$36.1K	﹤0.01%	4362

Other funds holding GPCR

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $72.4B AUM 31.32% 1-Year Est. Return

Pacific Heights Asset Management San Francisco, California $3.1B AUM 37.54% 1-Year Est. Return

SEB Asset Management Stockholm $27B AUM

Universal-Beteiligungs- und Servicegesellschaft Frankfurt Am Main, Germany $65.3B AUM 33.78% 1-Year Est. Return

Peregrine Capital Management Minneapolis, Minnesota $2.95B AUM 28.43% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Squarepoint New York $90.8B AUM 26.98% 1-Year Est. Return

ALPS Advisors Denver, Colorado $21.8B AUM 17.58% 1-Year Est. Return

Nuveen's GPCR Position: Q3 2026 in Review

Nuveen opened a new position in Structure Therapeutics (GPCR) in Q3 2026: 770 shares worth $25.2K. The stake represents ﹤0.01% of the portfolio and ranks #4362 among its holdings.

66 funds tracked by Wall St. Rank hold GPCR as of Q3 2026.

Nuveen held 770 shares of Structure Therapeutics worth $25.2K as of Q3 2026.
Structure Therapeutics was a new Nuveen position in Q3 2026.
Structure Therapeutics made up ﹤0.01% of Nuveen's portfolio in Q3 2026, its #4362 holding.
66 funds tracked by Wall St. Rank held Structure Therapeutics as of Q3 2026.

Based on Nuveen's 13F filing for Q3 2026, filed 10 Nov 2026.